Ontario's MoH Approves Rituxan's Reimbursement For Pemphigus Vulgaris

The Government of Ontario's Ministry of Health (MoH) and Long-Term Care has decided to fund Roche's Rituxan (rituximab) for the treatment of pemphigus vulgaris through the Ontario Public Drug Programs - Exceptional Access Program.

The Canadian Pemphigus and Pemphigoid Foundation was involved in this process, and has encouraged other provinces and territories to follow the Government of Ontario's lead.

Ontario's MoH Approves Rituxan's Reimbursement For Pemphigus Vulgaris

The Government of Ontario's Ministry of Health (MoH) and Long-Term Care has decided to fund Roche's Rituxan (rituximab) for the treatment of pemphigus vulgaris through the Ontario Public Drug Programs - Exceptional Access Program.

The Canadian Pemphigus and Pemphigoid Foundation was involved in this process, and has encouraged other provinces and territories to follow the Government of Ontario's lead.

×

Enter your details to read the full article

By submitting this form you are acknowledging that you have read and understood our Privacy Policy.

×

REQUEST A DEMO

By submitting this form you are acknowledging that you have read and understood our Privacy Policy.

Thank you for your interest

A member of the team will be in touch shortly to arrange a convenient time for your free demonstration and trial. If your enquiry is urgent, please email our Client Services team here.